Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants
- 26 September 2011
- journal article
- research article
- Published by Informa UK Limited in Xenobiotica
- Vol. 42 (2), 173-178
- https://doi.org/10.3109/00498254.2011.615954
Abstract
To determine the effect of genistein on cytochrome P450 3A (CYP3A) and P-glycoprotein (P-gp) function using the probe substrates midazolam and talinolol, respectively. Eighteen healthy adult male participants were enrolled in a two-phase randomized crossover design. In each phase, the participants received placebo or genistein for 14 days. On the 15th day, midazolam and talinolol were administered and blood samples were obtained. Midazolam and talinolol pharmacokinetic parameter values were calculated and compared before and after genistein administration. Co-administration of genistein decreased the area under the concentration-time curve from 0 to 36 h (AUC 0-36) (143.65 ± 55.40 ng h/mL versus 126.10 ± 40.14 ng h/mL, p < 0.05), and the area under the concentration-time curve from zero to infinity (AUC 0-∞) (209.18 ± 56.61 ng h/mL versus 180.59 ± 43.03 ng h/mL, p < 0.05), and also maximum concentration (Cmax) of midazolam (48.86 ± 20.21 ng/mL versus 36.25 ± 14.35 ng/mL p < 0.05). Similarly, AUC 0-36 (2490.282 ± 668.79 ng h/mL versus 2114.46 ± 861.11 ng h/mL, p < 0.05), AUC 0-∞ (2980.45 ± 921.09 ng h/mL versus 2626.92 ± 1003.78 ng h/mL, p < 0.05) and Cmax of talinolol (326.58 ± 197.67 ng/mL versus 293.42 ± 127.19 ng/mL, p < 0.05) were reduced by genistein co-administration. The oral clearance of midazolam (1.68 ± 0.85 h-1 versus 3.98 ± 0.59 h-1, p < 0.05) and talinolol (3.34 ± 1.24 h-1 versus 3.79 ± 1.55 h-1, p<0.05) were increased by genistien significantly. Administration of genistein can result in a modest induction of CYP3A and possibly P-gp activity in healthy volunteers.Keywords
This publication has 33 references indexed in Scilit:
- Evaluation of In Vivo P-Glycoprotein Phenotyping ProbesClinical Pharmacokinetics, 2010
- Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical ObservationsThe AAPS Journal, 2009
- Human CYP3A4 and Murine Cyp3A11 Are Regulated by Equol and Genistein via the Pregnane X Receptor in a Species-Specific MannerJournal of Nutrition, 2009
- Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymesThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugsPharmacology & Therapeutics, 2006
- Variability of Intestinal Expression of P-Glycoprotein in Healthy Volunteers as Described by Absorption of Talinolol from Four Bioequivalent TabletsJournal of Pharmaceutical Sciences, 2003
- Soy isoflavonoids and cancer — metabolism at the target siteMutation Research, 2001
- Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by RifampinPublished by Elsevier BV ,2001
- P-Glycoprotein (P-gp) Mediated Efflux in Caco-2 Cell Monolayers: The Influence of Culturing Conditions and Drug Exposure on P-gp Expression LevelsJournal of Pharmaceutical Sciences, 1998
- Soy feeding induces phase II enzymes in rat tissuesNutrition and Cancer, 1997